Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Journal of Human Hypertension
|
May 28, 2010
Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study
A C K Larstorp, P M Okin, R B Devereux, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 20, 2005
Impairment of cardiac function in hypertensive patients with Type 2 diabetes: a LIFE study
P Hildebrandt, K Wachtell, B Dahlöf, et al.
Journal of Diabetes and Its Complications
|
May 21, 2025
Physical activity and albuminuria in individuals recently diagnosed with type 2 diabetes
T Norlén, T B Olesen, S L Domazet, et al.
British Journal of Cancer
|
February 27, 2015
Who are the cancer survivors? A nationwide study in Denmark, 1943-2010
H B Hovaldt, N P Suppli, M H Olsen, et al.
Journal of Human Hypertension
|
June 6, 2008
Impact of the metabolic syndrome on the predictive values of new risk markers in the general population
M H Olsen, T W Hansen, M K Christensen, et al.
Journal of Human Hypertension
|
September 12, 2008
New risk markers may change the HeartScore risk classification significantly in one-fifth of the population
M H Olsen, T W Hansen, M K Christensen, et al.
Journal of Human Hypertension
|
May 21, 2003
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy
M H Olsen, E Hjerkinn, K Wachtell, et al.
Journal of Human Hypertension
|
April 2, 2004
24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy
N Wiinberg, L E Bang, K Wachtell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 14, 2009
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study
G de Simone, P M Okin, E Gerdts, et al.
Atherosclerosis
|
March 1, 2011
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events
T Sehestedt, S Lyngbæk, J Eugen-Olsen, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Journal of Human Hypertension
|
May 28, 2010
Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study
A C K Larstorp, P M Okin, R B Devereux, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 20, 2005
Impairment of cardiac function in hypertensive patients with Type 2 diabetes: a LIFE study
P Hildebrandt, K Wachtell, B Dahlöf, et al.
Journal of Diabetes and Its Complications
|
May 21, 2025
Physical activity and albuminuria in individuals recently diagnosed with type 2 diabetes
T Norlén, T B Olesen, S L Domazet, et al.
British Journal of Cancer
|
February 27, 2015
Who are the cancer survivors? A nationwide study in Denmark, 1943-2010
H B Hovaldt, N P Suppli, M H Olsen, et al.
Journal of Human Hypertension
|
June 6, 2008
Impact of the metabolic syndrome on the predictive values of new risk markers in the general population
M H Olsen, T W Hansen, M K Christensen, et al.
Journal of Human Hypertension
|
September 12, 2008
New risk markers may change the HeartScore risk classification significantly in one-fifth of the population
M H Olsen, T W Hansen, M K Christensen, et al.
Journal of Human Hypertension
|
May 21, 2003
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy
M H Olsen, E Hjerkinn, K Wachtell, et al.
Journal of Human Hypertension
|
April 2, 2004
24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy
N Wiinberg, L E Bang, K Wachtell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 14, 2009
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study
G de Simone, P M Okin, E Gerdts, et al.
Atherosclerosis
|
March 1, 2011
Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events
T Sehestedt, S Lyngbæk, J Eugen-Olsen, et al.
Page
of 5